Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Hersh Patel

Pain Medicine Newark, DE Medical Doctor

NPI 1912345950 CMS profile 446158

4755 Ogletown Stanton Rd Ste 231, Newark, DE 19718

Open in the dashboard

General payments

$104,015

193 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$1,025 paid to institutions, not to them · program year 2021

Through program year 2025, Hersh Patel of Newark, DE is reported in the CMS Open Payments database as having received $104,015 across 193 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $1,025 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Pain Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $35,320 12
2024 General $30,565 14
2023 General $10,415 7
2022 General $11,827 38
2021 General $10,417 36
2020 General $986 26
2019 General $4,485 60

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Hersh Patel
  • Pain Medicine median
  • Middle half of Pain Medicine
  • National median

In program year 2025, general payments to Hersh Patel were reported at $35,320. Among 2,779 Pain Medicine profiles paid that year, the median was $458 and the middle half received between $124 and $1,401.

Show as a table
Year Hersh Patel Pain Medicine median Middle half National median
2019 $4,485 $498 $126–$1,682 $163
2020 $986 $284 $80–$910 $114
2021 $10,417 $399 $112–$1,219 $132
2022 $11,827 $455 $137–$1,484 $149
2023 $10,415 $484 $128–$1,495 $160
2024 $30,565 $498 $131–$1,540 $164
2025 $35,320 $458 $124–$1,401 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Takeda Pharmaceuticals U.S.A., Inc. $75,015 28 payments
  2. GRT US Holding, Inc. $19,920 42 payments
  3. Medtronic USA, Inc. $1,909 38 payments
  4. Nevro Corp. $1,886 21 payments
  5. Arthrex, Inc. $1,364 3 payments
  6. Averitas Pharma Inc. $1,268 4 payments
  7. Abbott Laboratories $1,208 22 payments
  8. Medtronic, Inc. $523 17 payments
  9. Vertos Medical, Inc. $458 5 payments
  10. Liberty Surgical, Inc $313 3 payments
  11. Other $150 10 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $83,551 30 payments
  2. Honoraria $8,450 6 payments
  3. Travel and Lodging $6,084 26 payments
  4. Food and Beverage $4,730 130 payments
  5. Education $1,200 1 payment
Products named General payments · program years 2019–2025
  1. Qutenza $21,188 46 payments
  2. Senza Spinal Cord Stimulation System $1,855 19 payments
  3. INTELLIS $1,219 17 payments
  4. Proclaim Family of SCS IPGs $808 8 payments
  5. VECTRIS Spinal Cord Neurostimulation $556 19 payments
  6. mild Device Kit $443 4 payments
  7. SlimTip lead DRG Lead $219 3 payments
  8. Octrode SCS Leads $173 10 payments
  9. VECTRIS Spinal Cord Neurostimulation $152 3 payments
  10. SPECIFY $123 1 payment
  11. Other $585 31 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

193 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record